Clinical Trial Update: Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure [Phase 2]

View source ↗

Summary

A Phase 2 study of aromatase inhibitors in premenopausal breast cancer patients with chemotherapy-induced ovarian failure was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-06-19